BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 21, 2014
View Archived Issues
Takeda Pharmaceutical discloses new CH24H inhibitors
Read More
Astex Therapeutics patents novel IAP inhibitors for cancer
Read More
Novel biomarkers for Cushing's syndrome, HDR syndrome and MEN1 identified
Read More
Preclinical and early clinical data presented for prodrug of Debio-1452
Read More
Enantiomer switching of an existing drug unveils novel mechanism of action against cancer cells
Read More
GSK-2339345 proves safe in phase I trials for chronic cough
Read More
Kymab secures funding to advance clinical development of antibody therapeutics
Read More
FDA orphan status granted to diazoxide choline
Read More
ADC Therapeutics and MedImmune to advance ADCT-401 into clinic
Read More
Phase II results presented for relamorelin in chronic constipation, diabetic gastroparesis
Read More
Cellceutix reports promising findings for brilacidin in diabetic wound model
Read More
Sorrento Therapeutics discloses new antibodies for S. aureus infection
Read More
KineMed and CHDI Foundation expand Huntington's disease collaboration
Read More
Provista Diagnostics initiates clinical study of blood assay for breast cancer
Read More
Senesco Technologies completes acquisition of Fabrus
Read More
Agenix to sell its tenofovir prodrug
Read More
BioAlliance's Livatag receives FDA fast track designation
Read More
Ophthotech licenses ex-U.S. rights to Fovista to Novartis
Read More
Bioenergenix discloses novel hPASK inhibitors
Read More
Dainippon Sumitomo Pharma synthesizes new mGlu5 receptor modulators
Read More
MOR-208 receives FDA and EMA orphan drug designations
Read More
AADi in-licenses nanotechnology-based drug
Read More
Merck KGaA proposes global alliance against schistosomiasis
Read More
GSK and Genmab report topline data from pivotal head-to-head study of ofatumumab
Read More
Isis Pharmaceuticals begins phase I study of ISIS-PKK-Rx
Read More
Takeda achieves FDA approval for vedolizumab
Read More